MEDX Holdings Information

MEDX is an equity ETF with a total of 34 individual holdings. The top holdings are Eli Lilly and Company stock at 18.50%, AbbVie at 8.72%, US BANK MMDA - USBGFS 7 at 7.01%, Novartis AG ADR at 6.72%, and Johnson & Johnson at 5.72%.

Total Holdings

Top 10 Percentage

70.29%

Asset Class

Equity

ETF Category

Health

Assets

17.92M

PE Ratio

23.82

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	18.50%	2,936
2	ABBV	AbbVie Inc.	8.72%	6,712
3	n/a	US BANK MMDA - USBGFS 7	7.01%	1,375,409
4	NVSN.MX	Novartis AG ADR	6.72%	8,388
5	JNJ	Johnson & Johnson	5.72%	4,200
6	ALKS	Alkermes plc	5.67%	20,132
7	LON: AZN	AstraZeneca PLC	4.94%	5,015
8	IONS	Ionis Pharmaceuticals, Inc.	4.80%	10,904
9	BMY	Bristol-Myers Squibb Company	4.33%	14,644
10	AMGN	Amgen Inc.	3.87%	2,062
11	MRK	Merck & Co., Inc.	3.86%	5,872
12	ALNY	Alnylam Pharmaceuticals, Inc.	3.56%	2,168
13	CRSP	CRISPR Therapeutics AG	2.86%	9,228
14	BIIB	Biogen Inc.	2.86%	2,726
15	PFE	Pfizer Inc.	2.78%	22,648
16	GSK	GSK plc	2.68%	9,846
17	REGN	Regeneron Pharmaceuticals, Inc.	2.17%	630
18	BEAM	Beam Therapeutics Inc.	1.62%	8,388
19	NTLA	Intellia Therapeutics, Inc.	1.12%	12,584
20	GALT	Galectin Therapeutics Inc.	1.10%	46,968
21	SDZNY	Sandoz Group AG	0.74%	1,680
22	REPL	Replimune Group, Inc.	0.74%	12,584
23	VNDA	Vanda Pharmaceuticals Inc.	0.74%	22,648
24	HLN	Haleon plc	0.62%	12,309
25	EDIT	Editas Medicine, Inc.	0.53%	27,680

Showing 25 of 34 holdings

Subscribe to see the full list

Activate Now

As of Jul 7, 2026